Background In the early nineties, Norway reported the highest incidence of inflammatory
bowel disease (IBD) worldwide (18.8 per 100000 per year). 1 Subsequently, significant …

Background and aim Modern treatment strategies for inflammatory bowel disease (IBD) are
postulated to change the natural disease course. Inception cohort studies are the gold …

Background & Aims Shifts in epidemiological stages of inflammatory bowel disease (IBD)
carry implications toward understanding IBD etiology and managing clinical care. We …

Dear Editors: We commend Agrawal et al 1 for a well-conducted study on the incidence and
prevalence of inflammatory bowel disease (IBD) in Denmark from 1995 to 2016. They found …

Background Mitigating the burden of inflammatory bowel disease (IBD) in Western countries
requires understanding how its epidemiology is evolving. We conducted a temporal analysis …

A study by A. Jussila et al. 1 published by the journal last August featured an estimation of
rising IBD prevalence in Finland by using a registry for state-reimbursed medicines but the …

Background A recent systematic review reports stabilising or falling IBD incidence in
Western countries with an overall prevalence in excess of 0.3%. 1 However, the true …

Background Regional studies on inflammatory bowel disease (IBD) suggest an increasing
prevalence over time, but no nationwide estimate has been published so far. Aim To …

Background Countries have different diagnostic procedures and treatment regimens for
inflammatory bowel disease (IBD) patients. In addition to differences in population …

Background Globally, the incidence rates of inflammatory bowel disease (IBD) are
increasing; however, data from high‐incidence areas are conflicting. Previous studies in …